Shares of Neuralstem were exploding in Tuesday trading and closed the day up 175% after revealing successful updated Phase 2 clinical data in its depressive disorder trial of NSI-189. The results were presented at the 56th American College of Neuropsychopharmacology (ACNP) Annual meeting in a poster presentation entitled, “A Phase 2, Double-Blind, Placebo-Controlled Study of … Continue reading “Neuralstem Explodes on Positive Phase 2 Clinical Data”
Biotech & Pharma
First Digital Pill is Approved by the FDA
There's now a way for doctors to truly know if a patient has taken their…
Novartis to Buy This Big French Drug Maker for $3.9 Billion
Novartis AG announced on Monday that it will be acquiring Advanced Accelerator Applications, a French…
Pfizer to Sell its Consumer Healthcare Business in November
According to a Reuters report which cited two people close to the matter who remain…
Novartis Climbs Higher After Earnings Rise
Shares of Swiss pharmaceuticals company Novartis saw its share price climb higher on Tuesday after…
Gilead Shares Move Higher After FDA Approves its Cancer Drug
Gilead made an excellent move acquiring Kite Pharma because a drug that Kite developed has…
Merck Shares Explode After Citi Upgrade
It was a strong day for pharmaceutical company Merck on Wednesday. The stock's shares started…
Zogenix Shares Double on Epilepsy Treatment Results
Shares of biotech stock Zogenix had an exciting trading day on Friday after the company…
The FDA Has Approved the First Finger Prick-Free Diabetes Device
Millions of Americans may be thrilled to learn that the Food & Drug Administration has…
Bristol-Myers Squibb Gets FDA Approval for its Liver Drug Opdivo
It was an exciting day for Bristol-Myers Squibb on Monday. The Food and Drug Administration…
A Test that Can Detect Cocaine in Seconds Using a Fingerprint
Imagine being able to know if someone has been using cocaine recently in just seconds…
This U.S Drug maker Just Said it Will Lay off 20% of Its Workforce
U.S drug maker Alexion announced this week that it would be slashing 20% of its…
This Major Drug Maker Will Cut its Work Force by 9%
Indianapolis-based Eli Lilly announced on Thursday that the company will be cutting almost 9% of…
Novartis AG CEO Resigns Suddenly
The CEO of Novarti AG has suddenly resigned. Chief Executive Officer Joseph Jimenez has been…
